The Matriks Biotek Shikari® Ramucirumab ELISA has been especially developed for the quantitative analysis of free Ramucirumab in serum and plasma.
10ul
70 min
Serum, plasma
96
10ng/mL
85-115%
1 year
The Matriks Biotek® Antibody to Ramucirumab (Cyramza®) Enzyme-Linked-ImmunoSorbent-Assay (ELISA) Kit is intended for the qualitative determination of antibodies to Ramucirumab (Cyramza®)in serum and plasma. The Matriks Biotek SHIKARI® Antibody to Ramucirumab ELISA Kit can be efficiently used for monitoring anti-Ramucirumab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti- Ramucirumab antibodies.
SHIKARI® Q-RAM & S-ATRAM
Ramucirumab (Cyramza®)
Enzyme immunoassay for the quantitative determination of free Ramucirumab (Cyramza®) in serum and plasma
Enzyme immunoassay for the qualitative determination of antibodies to Ramucirumab in serum and plasma
Required Volume
Total Time
Sample
Sample Number
Detection Limit
Spike Recovery
Shelf Life
10ul
140 min
Serum, plasma
96
+/-
-
1 year
RAM-FD-CYR: $1000.00 Lead time: 1-2 weeks
RAM-QLS-CYR: $945.00 Lead time: 1-2 weeks
.....................................................
.....................................................
541 Taylor Way Suite# 4
San Carlos, CA 94070
Phone : (650) 486-1541
Fax : (650) 394-8638
Open weekdays 9 AM-6 PM (PST)
.........................................................................................................................................................................................................................................................
Required Volume
Total Time
Sample
Sample Number
Detection Limit
Spike Recovery
Shelf Life